Molecular mechanism of interferon alfa-Mediated growth inhibition in human neuroendocrine tumor cells

Gastroenterology

Volumn 118, Issue 4, 2000, Pages 735-748

  Detjen, Katharina M ^a   Welzel, Martina ^a   Farwig, Katrin ^a   Brembeck, Felix H ^b   Kaiser, Astrid ^b   Riecken, Ernst Otto ^b   Wiedenmann, Bertram ^a   Rosewicz, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Abbreviations; dithiothreitol; DMEM; DTT; Dulbecco's modified Eagle medium; FCS; fetal calf serum; gastroenteropancreatic; GED; IFN; interferon; interferon stimulated response element; ISRE; phenylmethylsulfonyl fluoride; PKR; PMSF; RNA dependent protein kinase; SDS PAGE; sodium dodecyl sulfate polyacrylamide gel electrophoresis

Indexed keywords

ALPHA INTERFERON RECEPTOR; CELL CYCLE PROTEIN; CYCLIN B; RECOMBINANT ALPHA INTERFERON; STAT PROTEIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIGAND BINDING; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

EID: 0034103423     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70143-0     Document Type: Article

References (59)

1. W Creutzfeldt Endocrine tumors of the pancreas E Arquilla, BW Volks, The diabetic pancreas 1985 Plenum New York 534 563
2. B Wiedenmann, M John, Ahnert-Hilgert, and E-O Riecken Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system J Mol Med 76 1998 637 647
3. R Arnold, and M Frank Control of growth in neuroendocrine gastro-enteropancreatic tumors Digestion 57 1996 69 71
4. S Faiss, H Scherübl, EO Riecken, and B. Wiedenmann Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system Recent Results Cancer Res 142 1996 193 207
5. M Frank, KJ Klose, M Wied, N Ishaque, C Schade-Brittinger, and R Arnold Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropan-creatic tumors Am J Gastroenterol 94 1999 1381 1387
6. M di Bartolomeo, E Bajetta, R Buzzoni, L Mariani, C Carnaghi, L Somma, N Zilembo, and A di Leo Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group Cancer 77 1996 402 408
7. K. Öberg Advances in chemotherapy and biotherapy of endocrine tumors Curr Opin Oncol 10 1998 58 65
8. CG Moertel, LK Kvols, MJ O'Connell, and J Rubin Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms Cancer 68 1991 227 232
9. CG Moertel, M Lefkopoulo, S Lipsitz, RG Hahn, and D Klaassen Streptozotocin-doxorubicin, streptozotocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma N Engl J Med 326 1992 519 523
10. K. Öberg Interferon- versus somatostatin or the combination of both in gastroenteropancreatic tumours Digestion 57 1996 81 83
11. K. Öberg The action of interferon alpha on human carcinoid tumours Semin Cancer Biol 3 1992 35 41
12. K. Öberg Interferons in the management of neuroendocrine tumors and their possible mechanism of action Yale J Biol Med 65 1992 519 529
13. D Grander, O Sangfelt, and S Erickson How does interferon exert its cell growth inhibitory effect? Eur J Haematol 59 1997 129 135
14. JE Darnell Jr, IM Kerr, and GR Stark Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
15. H Nguyen, J Hiscott, and PM Pitha The growing family of interferon regulatory factors Cytokine Growth Factor Rev 4 1997 293 312
16. T Arora, and DF Jelinek Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression J Biol Chem 273 1998 11799 11805
17. R Kumar, and I Atlas Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation Proc Natl Acad Sci USA 89 1992 6599 6603
18. Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK) Oncogene 16 1998 217 225
19. D Resnitzky, N Tiefenbrunn, H Berissi, and A Kimchi Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoetic cells Proc Natl Acad Sci USA 89 1992 402 406
20. PS Subramaniam, and HM Johnson A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons J Interferon Cytokine Res 17 1997 11 15
21. N Tiefenbrun, D Melamed, N Levy, D Resnitzky, I Hoffman, SI Reed, and A Kimchi Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest Mol Cell Biol 16 1996 3934 3944
22. T Raveh, AG Hovanessian, EF Meurs, N Sonenberg, and A. Kimchi Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons J Biol Chem 271 1996 25479 25484
23. D Resnitzky, and A Kimchi Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells Cell Growth Differ 2 1991 33 41
24. V Gouyer, S Gazzéri, I Bolon, C Drevet, C Brambilla, and E. Brambilla Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors Am J Resp Cell Mol Biol 18 1998 188 196
25. DG Wang, CF Johnston, and KD Buchanan Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis Cancer 80 1997 668 675
26. M Simboli-Campbell, A Gagnon, DJ Franks, and J Welsh 1,25-Dihydroxyvitamin D3 translocates protein kinase C beta to nucleus and enhances plasma membrane association of protein kinase C alpha in renal epithelial cells J Biol Chem 269 1994 3257 3264
27. S Bhattacharya, R Eckner, S Grossman, E Oldread, Z Arany, A D'Andrea, and DM Livingston Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha Nature 383 1996 344 347
28. M Höcker, RJ Henihan, S Rosewicz, EO Riecken, Z Zhang, TJ Koh, and TC. Wang Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells J Biol Chem 272 1997 27015 27024
29. S Rosewicz, M Weder, A Kaiser, and EO Riecken Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes Gut 39 1996 255 261
30. M Ruas, and G Peters The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim Biophys Acta 1378 1998 F115 F177
31. MR Toliat, W Berger, HH Ropers, P Neuhaus, and B Wiedenmann Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system (letter) Lancet 350 1997 1223
32. S Wang, SK Tyring, CM Townsend Jr, and BM Evers Interferon-mediated activation of the Stat signaling pathway in a human carcinoid tumor Ann Surg Oncol 5 1998 642 649
33. JF Bromberg, CM Horvath, Z Wen, RD Schreiber, and JE Darnell Jr Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma Proc Natl Acad Sci USA 93 1996 7673 7678
34. MA Meraz, JM White, KC Sheehan, EA Bach, SJ Rodig, AS Dighe, DH Kaplan, JK Riley, AC Greenlund, D Campbell, K Carver-Moore, RN DuBois, R Clark, M Aguet, and RD Schreiber Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the Jak-Stat signaling pathway Cell 84 1996 431 442
35. PM Grimley, H Fang, H Rui, EF Petricoin III, S Ray, F Dong, KH Fields, R Hu, KC Zoon, S Audet, and J Beeler Prolonged Stat1 activation related to the growth arrest of malignant lymphoma cells by interferon-alpha Blood 91 1998 3017 3027
36. Y Zhou, A Gobl, S Wang, MB Jacobsen, ET Janson, GK Haines III, JA Radosevich, and K. Öberg Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours Eur J Cancer 34 1998 2046 2052
37. O Sangfelt, S Erickson, J Castro, T Heiden, S Einhorn, and D Grander Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines Cell Growth Differ 8 1997 343 352
38. H Yano, A Iemura, M Haramaki, S Ogasawara, A Takayama, J Akiba, and M Kojiro Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines Hepatology 29 1999 1708 1717
39. K Zhang, and R. Kumar Interferon- inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with Rb protein and E2F in Daudi cells Biochem Biophys Res Commun 200 1994 522 528
40. cip in mouse macrophages Oncogene 16 1998 2075 2086
41. kip mRNA in IFN-sensitive and resistant cell lines Biochem Biophys Res Commun 245 1998 752 756
42. AC Hobeika, PS Subramaniam, and HM. Johnson IFN induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells Oncogene 14 1997 1165 1170
43. M Zamanian-Daryoush, SD Der, and BR Williams Cell cycle regulation of the double stranded RNA activated protein kinase, PKR Oncogene 18 1999 315 326
44. I Arany, P Rady, BM Evers, SK Tyring, and CM Townsend Jr Analysis of multiple molecular changes in human endocrine tumors Surg Oncol 3 1994 153 159
45. JI Garrison, ME Berens, JR Shapiro, S Treasurywala, and G Floyd-Smith Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines J Neurooncol 30 1996 213 223
46. LR Panniers, and MJ Clemens Inhibition of cell division by interferon: changes in cell cycle characteristics and in morphology of Ehrlich ascites tumour cells in culture J Cell Sci 48 1981 259 279
47. D Lundblad, and E Lundgren Block of a glioma cell line in S by interferon Int J Cancer 27 1981 749 754
48. D Killander, P Lindahl, P Leary, and I Gresser Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L1210 cells and their position in the cell cycle Eur J Immunol 6 1976 56 59
49. HD Preisler, V Gopal, SD Banavali, D Finke, and SA Bokari Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents Cancer Res 52 1992 4090 4095
50. S Ohwada, I Kobayashi, M Maemura, Y Satoh, T Ogawa, Y Iino, and Y Morishita Interferon potentiates antiproliferative activity of CPT-11 against human colon cancer xenografts Cancer Lett 110 1996 149 154
51. XQ Qin, L Runkel, C Deck, C DeDios, and J Barsoum Interferon-beta induces S phase accumulation selectively in human transformed cells J Interferon Cytokine Res 17 1997 355 367
52. MR Jackman, and JN Pines Cyclins and the G2/M transition Cancer Surv 29 1997 47 73
53. A Moro, K Zerfass, S Joswig, and P Jansen-Duerr Effect of cyclins and Cdks on the cyclin B1 promoter activation Biochem Mol Biol Int 41 1997 919 924
54. J DeGregori, T Kowalik, and JR Nevins Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes Mol Cell Biol 15 1995 4215 4224
55. S Iwase, Y Furukawa, J Kikuchi, M Nagai, Y Terui, M Nakamura, and H Yamada Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells J Biol Chem 272 1997 12406 12414
56. D Melamed, N Tiefenbrun, A Yarden, and A Kimchi Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells Mol Cell Biol 13 1993 5255 5265
57. A Hwang, WG McKenna, and RJ. Muschel Cell cycle-dependent usage of transcriptional start sites. A novel mechanism for regulation of cyclin B1 J Biol Chem 273 1998 31505 31509
58. JD Thatcher, B McBride, and KS Katula Promoter binding factors regulating cyclin B transcription in the sea urchin embryo DNA Cell Biol 14 1995 869 881
59. CL Dent, KA Lillycrop, A Bybee, DS Latchman, and NS Thomas Interferon-alpha treatment of Daudi cells down-regulates the octamer binding transcription/DNA replication factors Oct-1 and Oct-2 J Biol Chem 266 1991 20888 20892